|
US2012328563A1
|
|
CD4+CD25+ regulatory T cells from human blood
|
|
EP2261258A1
|
|
MCSP-aligned scFv antibody fragments and use of same
|
|
US2007154877A1
|
|
Method for the direct culture of dendritic cells without a preceding centrifugation step
|
|
WO2006045750A2
|
|
T-cell stimulatory peptides from the melanoma-associated chondroitin sulfate proteoglycan and their use
|
|
EP1658844A1
|
|
Use of artemisinin derivatives in the manufacture of a medicament for the treatment of melanoma
|
|
EP1391210A2
|
|
Regulatory medicament comprising CD4+CD25- T cells and Tr1-like regulatory cells
|
|
US8222033B2
|
|
CD4+CD25− T cells and Tr1-like regulatory T cells
|
|
EP1391504A1
|
|
CD4+ CD25- T cells and Tr1-like regulatory T cells
|
|
EP1279728A1
|
|
Generation of fully mature and stable dentritic cells from leukapheresis products for clinical applications
|
|
EP1270732A1
|
|
Improved transfection of eukaryontic cells with linear polynucleotides by electroporation
|
|
EP1241249A1
|
|
CD4+CD25+regulatory T cells from human blood
|
|
DE10041515A1
|
|
Process for the production of ready-to-use, antigen-loaded or unloaded, cryopreserved mature dendritic cells
|
